Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL

NCT07554820 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Major Adverse Cardiac Events

Interventions

DRUG: Tofacitinib 5 MG

Sponsor

Shaikh Zayed Hospital, Lahore